The debate about whether the NHS should use magic mushrooms to treat depression
Pallab Ghosh
2 January 2026
BBC
’Shrooms Lead the Pack in Psychedelic Medicine, but Rollout Is Bumpy
And a related article not about therapy but creativity:
How Psychedelics Can Catalyze Creative Breakthroughs
Cassandra Vieten, PhD
January 14, 2026
IONS blog
Pallab Ghosh
2 January 2026
BBC
Quote:Prof Oliver Howes, chair of the Royal College of Psychiatrists' Psychopharmacology Committee, is optimistic. He says he sees psychedelics as a promising potential new treatment for psychiatric disorders - including for patients in the NHS.
Quote:Others have also urged caution. A report by the Royal College of Psychiatrists, published in September 2025, warned of the potential dangers of psychedelics, and doctors also stress that taking psychedelic drugs is not just illegal but can also be harmful.
Quote:Dr Das believes positive results from trials might change views as the emerging scientific evidence mounts. "I hope if there's sufficient evidence, the government will be open to revising the scheduling of these drugs," he says.
However, an analysis, published in the British Medical Journal in November 2024 by a PhD student Cédric Lemarchand and colleagues, questioned how easy it was to determine the precise effect of psychedelic drugs.
"Because hallucinogens are often combined with a psychotherapy component, it is difficult to separate the effects of the drug from the therapeutic context, complicating comprehensive evaluations and product labelling."
It also suggested short-term trials may not detect "the potential for harm and serious adverse events from long-term use of hallucinogens… The potential for abuse or misuse must also be considered."
’Shrooms Lead the Pack in Psychedelic Medicine, but Rollout Is Bumpy
Quote:More than 18,000 people have already gone through Oregon’s psilocybin program, and the early data on adverse events has been positive.
According to the Oregon Health Authority, there have been 23 incidents requiring emergency services, which experts consider low. Many of the calls involved clients in distress who sought to prematurely leave their session against the advice of a facilitator.
Angela Allbee, who oversees psilocybin services at the Oregon Health Authority, said that none of the incidents were serious.
“Statistically speaking, psilocybin therapy is safer than golfing,” said Ryan Reid, the operations director and co-founder of Bendable Therapy in Bend. “It’s safer than anyone thought it would be.”
That said, Oregon prohibits those with schizophrenia and active psychosis from participating in the program, because the drug can trigger or exacerbate manic and psychotic symptoms. For those without serious psychiatric diagnoses, the side effects can include headaches, nausea, anxiety and fluctuations in blood pressure.
Psilocybin’s therapeutic benefits are tied to the drug’s ability to temporarily rewire the brain, helping patients break the cycle of negative thinking that is the hallmark of many hard-to-treat mental health conditions. In a therapeutic setting, the drug can provide fresh insights into unresolved childhood trauma, or help a terminally ill patient find joy in daily life, experts say.
“What we see reliably through all of these studies is that psilocybin gives people a new perspective on mental health issues, oftentimes when they’ve been stuck for years,” said Heidi Pendergast, the Oregon director of the Healing Advocacy Fund, which promotes state-regulated psychedelic therapy programs around the country. “It’s not a panacea, but it does give people a renewed sense of hope.”
And a related article not about therapy but creativity:
How Psychedelics Can Catalyze Creative Breakthroughs
Cassandra Vieten, PhD
January 14, 2026
IONS blog
Quote:Work by scholars such as Manesh Girn, who has recently completed a comprehensive review of psychedelics and creativity, is helping clarify how psychedelic states influence brain connectivity and thought dynamics in ways that may facilitate creative generation and novel insight.
Others, including Kalina Christoff, whose work investigates the neural and psychological mechanisms of spontaneous thought, mind-wandering, and creativity, are exploring how unconstrained cognition relates to imagination and insight. Another fantastic cognitive scientist Isabel Weissner investigates how psychedelics such as LSD alter cognitive processes related to creativity—showing that these substances can increase novelty, symbolic thinking, and semantic breadth in problem-solving while reshaping patterns of thought.
Up and coming are scholars like Christine Chesebrough who works to understand how altered states of consciousness influence imaginative and creative processes, and Nick Denomme, who investigates creative cognition and the psychological processes underlying novel idea generation are exploring how spontaneous thought, cognitive flexibility, and altered states intersect. And more senior researchers like Jonathan Schooler have long explored consciousness, mind-wandering, meta-awareness, and the cognitive underpinnings of creativity and problem-solving, emphasizing how fluctuations in attention and spontaneous thought contribute to insight. Together, this research is moving the conversation beyond anecdotes toward testable models.
![[-]](https://psiencequest.net/forums/images/collapse.png)